Tinea Pedis: Clinical Trials

70 trials for Tinea Pedis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

52 completed, 6 unknown, 4 recruiting, 3 not yet recruiting. 19 Phase 3, 17 Phase 2, 13 Phase 1, 11 Not applicable, 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 319Completed 15, Unknown 2, Terminated 1, Withdrawn 1
Phase 217Completed 13, Unknown 2, Recruiting 1, Terminated 1
Phase 113Completed 11, Recruiting 1, Terminated 1
Not applicable11Completed 7, Not yet recruiting 1, Recruiting 1, Unknown 1, Withdrawn 1
Phase 44Completed 3, Not yet recruiting 1
Early Phase 11Completed 1

Follow Tinea Pedis: new trials by email Literature Review of Tinea Pedis trials Research Report on Tinea Pedis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
In Vitro Susceptibility of Dermatophytes to Terbinafine and Itraconazole: MIC Distributions and Elevated-MIC Isolates in Faisalabad, Pakistan
In vitro antifungal susceptibility testing - Dermatophytosis, Tinea Corporis
RecruitingDr. Amara Safdar1202026-10-022026-10-27
A Phase 1b Study of ZYG24004 in Participants With Tinea Pedis Caused by Dermatophytes
ZYG24004 1% topical film-forming formulation, ZYG24004 3% topical film-forming formulation, Placebo topical formulation - Tinea Pedis
Phase 1RecruitingSinomune Pharmaceutical Co., Ltd642026-07-212026-08-04
Sports Nutrition Assessment Program
diet, Physical activity, body composition - Diet Habit, Body Weight
Not yet recruitingUniversity of Alicante1002025-10-012025-08-05
Atmospheric Pressure Cold Plasma for Moderate-to-severe Tinea Pedis
Active CAP therapy, Sham CAP therapy, standard care - Tinea Pedis
Not applicableRecruitingShenyang Medical College2202025-07-252026-01-02
Effect of Kinesiotaping on Lower Limb Kinematics and Functional Related Outcomes Among Female Athletes With Chronic Lateral Ankle Instability
Flexibility Exercise, Mulligan mobilization with movement, Kinesiology Taping - Kinesiotapping, Kinematics
Not applicableNot yet recruitingCairo University502025-06-302025-07-08
Advanced Footwear Technology in Federated Athletes
Survey of athletes - Athlete Foot
CompletedUniversity of Oviedo1342025-03-312026-05-01
Efficacy of Tropical Sertaconazole Nitrate 2% Vs Clotrimazole 1% for Tinea Pedis
Topical Sertaconazole 2%, Clotrimazole 1% - Tinea Pedis
Phase 4Not yet recruitingJinnah Postgraduate Medical Centre1002025-03-012025-03-11
Topical Tolnaftate Stick for Tinea Pedis: An Open-Label Interventional Study
1% Tolnaftate Stick Formula A, 1% Tolnaftate Stick Formula B, 1% Tolnaftate Stick Formula C - Tinea Pedis
Phase 2RecruitingPropedix, Inc.1502024-12-302025-11-28
Effectiveness of Balance Training and Dynamic Neuromuscular Stabilization Training in Amateur Athletes with Chronic Ankle Instability
Dynamic Neuromuscular Stabilization Training (DNS), Balance Training, Conventional Training - Ankle Inversion Sprain, Chronic Instability of Joint
Not applicableCompletedMedipol University362024-04-012024-12-19
A Morphological Study in Volleyball Athletes With Cronic Ankle Instability
Ankle Injuries, Instability; Ankle (Ligaments) (Old Injury)
UnknownHacettepe University242023-02-202023-07-06
A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis
DBI-001 Gel, DBI-002 Gel, Aqueous Gel - Tinea Pedis
Phase 2UnknownDermBiont, Inc.242022-09-082023-02-14
The Effect Of Plyometric Training On Balance And Proprioception In Different Branches Athletes
The effect of plyometric training on balance and proprioception in athletes in different branches - Athlete Foot
Not applicableCompletedmustafa gulsen542022-06-052023-03-03
Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis
UHE-103 Cream, Naftin (naftifine hydrochloride) Cream - Tinea Cruris, Tinea Pedis
Phase 1CompletedTherapeutics, Inc.422022-02-172024-04-10
A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis.
TA103, Placebo Control - Tinea Pedis
Early Phase 1CompletedSun Pharmaceutical Industries, Inc.1602020-09-032021-05-12
Study With BioCool Footcare in Subjects With Tinea Pedis Interdigitalis and Heel Cracks, Calluses and/or Dry Feet
Biocool Footcare - Foot Fungus, Tinea
Not applicableCompletedBiocool AB252020-03-032021-02-15
Neurodynamics to Improve Jump Functionality in Trampoline Jump Gymnasts
Neurodynamic training - Athlete Foot
Not applicableWithdrawnInvestigación en Hemofilia y Fisioterapia2020-03-022021-09-02
A Therapeutic Equivalence Study of Ketoconazole Cream 2%
Experimental: Ketoconazole 2% Cream (Douglas Pharmaceuticals America Ltd.), Active comparator: Ketoconazole 2% Cream (Teva Pharmaceuticals USA), Placebo comparator: Placebo (Douglas Pharmaceuticals America Ltd.) - Tinea Pedis
Phase 3CompletedDouglas Pharmaceuticals America Ltd6822019-12-112020-08-06
Curcuma Extract Beneficial for Muscle Damage
Ice cream - Athletes Foot
Not applicableCompletedUniversitas Muhammadiyah Semarang202019-04-082020-06-19
Effects of the Elastic Taping on the Chronic Ankle Instability
Tape with tension, Tape without tension - Ankle Sprains, Chronic Ankle Instability
Not applicableCompletedUniversidade Norte do Paraná272019-04-012020-09-29
A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis
UHE-103A1 cream, UHE-103A2 cream, UHE-103B cream - Tinea Pedis
Phase 2CompletedTherapeutics, Inc.2402019-03-152021-10-28

Showing 20 of 70. Sign in to see all of them.

Narrower conditions

Tinea Cruris (8)  ·  Mycoses (6)  ·  Tinea (6)  ·  Dermatomycoses (3)  ·  Onychomycosis (3)  ·  Ankle Injuries (2)  ·  Disease (2)  ·  Foot Diseases (2)  ·  Pruritus (2)  ·  Skin Diseases (2)  ·  Body Weight (1)  ·  Chronic Pain (1)  ·  Communicable Diseases (1)  ·  Feeding Behavior (1)

Broader conditions

Bacterial Infections and Mycoses (70)  ·  Pathological Conditions, Signs and Symptoms (70)  ·  Signs and Symptoms (70)  ·  Skin and Connective Tissue Diseases (70)  ·  Foot Dermatoses (69)  ·  Infections (69)  ·  Skin Diseases, Infectious (69)  ·  Skin Manifestations (69)  ·  Foot Diseases (68)  ·  Pruritus (68)  ·  Skin Diseases (68)  ·  Dermatomycoses (67)  ·  Mycoses (64)  ·  Tinea (64)  ·  Dermatitis (8)

Interventions

naftifine (8)  ·  Ketoconazole (4)  ·  Terbinafine (4)  ·  butenafine (4)  ·  1-(2-(2,4-dichlorophenyl)-2-(4-(trifluoromethyl)benzyloxy)ethyl)-1H-imidazole (3)  ·  Clotrimazole (2)  ·  Gels (2)  ·  BANG polymer gel (1)  ·  Body Composition (1)  ·  Compression Bandages (1)  ·  Diet (1)  ·  Exercise (1)  ·  Health Status (1)  ·  Ice Cream (1)  ·  Movement (1)

Sponsors

Sun Pharmaceutical Industries, Inc. (8)  ·  Merz North America, Inc. (4)  ·  AmDerma (3)  ·  Biolab Sanus Farmaceutica (2)  ·  DermBiont, Inc. (2)  ·  Medicis Global Service Corporation (2)  ·  Padagis LLC (2)  ·  Therapeutics, Inc. (2)  ·  Tinea Pharmaceuticals (2)  ·  Almirall, S.A. (1)  ·  Bausch & Lomb Incorporated (1)  ·  Bausch Health Americas, Inc. (1)  ·  Bayer (1)  ·  Biocool AB (1)  ·  Cairo University (1)

Countries

United States (29)  ·  Belize (5)  ·  Dominican Republic (5)  ·  Brazil (4)  ·  Puerto Rico (4)  ·  China (3)  ·  Honduras (3)  ·  Spain (3)  ·  Turkey (Türkiye) (3)  ·  Canada (2)  ·  Germany (2)  ·  Sweden (2)  ·  Australia (1)  ·  Egypt (1)  ·  El Salvador (1)

Top investigators

Anya Loncaric (2)  ·  Daniel Piacquadio, MD (2)  ·  Gilberto De Nucci, PhD (2)  ·  Lawrence Parish, MD (2)  ·  Ron Staugaard (2)  ·  Alan Fleischer, MD (1)  ·  Ali Rosidi, Doctor (1)  ·  Aynur Demirel, PhD (1)  ·  Carl Schanbacher, MD (1)  ·  Christoph Willers, MD, MBA (1)  ·  Chun Wah M. Yuen (1)

Results publications

PMID 22052309, PMID 31161942, PMID 41035081, PMID 42286623

NIH funding

2008 (1), 2009 (1)